Osteoarthritis and stem cell therapy

Most used adipose-derived stem cells (ADSCs)  or bone marrow-derived stem cells (BMSCs)  though the preparation varied within group. 57% of the sixty-one studies were level IV evidence, leaving five level I and nine level II studies containing 288 patients to be further analyzed. Eight studies used BMSCs, five ADSCs and one peripheral blood stem cells (PBSCs). The risk of bias in these studies showed five level I studies at low risk with seven level II at moderate and two at high risk.

 

Categories: Stem Cells therapy

NBScience

contract research organization

stem cell therapy